Related by context. All words. (Click for frequent words.) 78 sorafenib 77 bevacizumab 76 gefitinib 76 docetaxel 76 trastuzumab 75 gemcitabine 75 cetuximab 74 pemetrexed 73 bortezomib 73 imatinib 73 rituximab 73 temozolomide 72 sunitinib 72 lapatinib 72 capecitabine 71 temsirolimus 71 irinotecan 70 Tarceva 70 topotecan 70 sorafenib Nexavar 70 trabectedin 70 carboplatin 70 metastatic renal cell carcinoma 70 dasatinib 70 cisplatin 69 vandetanib 69 paclitaxel 69 pegylated liposomal doxorubicin 69 Erlotinib 69 FOLFIRI 68 Taxotere 68 bendamustine 68 Taxotere ® 68 azacitidine 68 advanced NSCLC 68 Targretin 68 nilotinib 67 decitabine 67 axitinib 67 mycophenolate mofetil 67 NSCLC 67 FOLFOX4 67 gefitinib Iressa 67 chlorambucil 67 Fludara 67 metastatic colorectal cancer 67 dacarbazine 67 docetaxel chemotherapy 67 Vectibix 67 zoledronic acid 67 etoposide 67 5 FU 67 chronic lymphocytic leukemia CLL 66 pomalidomide 66 anti TNF 66 taxane 66 mitoxantrone 66 Gefitinib 66 adalimumab 66 interferon alfa 66 vinorelbine 66 chemotherapeutic agent 66 HER2 positive metastatic breast 66 panitumumab 66 gemcitabine chemotherapy 66 sorafenib Nexavar ® 66 bevacizumab Avastin 66 lamivudine 66 oxaliplatin 65 seliciclib 65 amrubicin 65 erlotinib Tarceva 65 anastrozole 65 raltegravir 65 fluorouracil 65 infliximab 65 carboplatin paclitaxel 65 tocilizumab 65 erlotinib Tarceva ® 65 Hycamtin 65 Cytoxan 65 Tarceva TM 65 doxorubicin 65 5FU 65 Halaven 65 anti leukemic 64 methotrexate 64 daunorubicin 64 pioglitazone 64 iniparib 64 tamoxifen 64 etanercept 64 docetaxel Taxotere 64 imatinib Gleevec 64 FOLFOX 64 Doxil ® 64 idarubicin 64 Torisel 64 nab paclitaxel 64 antitumor activity 64 5-FU/LV 64 XELOX 64 pertuzumab 64 cabazitaxel 64 fludarabine 64 bortezomib Velcade 64 VIDAZA 64 gemcitabine Gemzar 64 Tarceva erlotinib 64 YONDELIS 64 Amrubicin 64 LY# [003] 64 EGFR tyrosine kinase inhibitors 64 imatinib therapy 64 Gleevec 64 Pemetrexed 64 clopidogrel 64 tyrosine kinase inhibitor 64 metformin 64 Bevacizumab 64 Herceptin trastuzumab 64 imetelstat 64 Xeloda 64 metastatic RCC 64 relapsed ovarian cancer 64 monotherapy 64 visilizumab 64 Velcade bortezomib 63 SCH # 63 exemestane 63 tyrosine kinase inhibitors 63 enzastaurin 63 chemotherapeutic agents 63 CANCIDAS 63 APTIVUS r 63 BAY #-# 63 EGFR TKIs 63 azathioprine 63 paclitaxel Taxol 63 letrozole 63 taxanes 63 Gemzar ® 63 tiotropium 63 cilengitide 63 heavily pretreated patients 63 Doxil 63 Bortezomib 63 vorinostat 63 idraparinux 63 rituximab Rituxan 63 olaparib 63 PLX# 63 neoadjuvant chemotherapy 63 cyclophosphamide 63 chemotherapy regimens 63 DMARD 63 ixabepilone 63 ritonavir boosted 63 insulin glargine 63 gemcitabine carboplatin 63 metastatic breast cancer 63 bicalutamide 63 free survival PFS 63 mTOR inhibitor 63 Tykerb 63 dasatinib Sprycel 63 EGFR mutations 63 Iressa 63 mRCC 63 clodronate 63 lapatinib Tykerb 63 bleomycin 63 lenalidomide 63 Taxol paclitaxel 63 paclitaxel chemotherapy 63 EGFR 63 docetaxel Taxotere R 63 Gemcitabine 63 plus dexamethasone 63 chemoradiation 63 enfuvirtide 63 protease inhibitor 63 NRTIs 62 DMARDs 62 chemoradiotherapy 62 thalidomide Thalomid 62 interferon 62 ipilimumab 62 Cetuximab 62 Femara 62 Trastuzumab 62 darunavir 62 vancomycin 62 pegylated interferon 62 vicriviroc 62 estramustine 62 adjuvant chemotherapy 62 Sutent 62 low dose dexamethasone 62 Taxotere R 62 cytarabine 62 Dasatinib 62 protease inhibitors 62 interferon alpha 62 5 fluorouracil 62 posaconazole 62 Sorafenib 62 RG# [001] 62 peginterferon 62 CHOP chemotherapy 62 Nexavar 62 sunitinib malate 62 TORISEL 62 mTOR inhibitors 62 epirubicin 62 IRESSA 62 pazopanib 62 Irinotecan 62 PXD# 62 hormone refractory prostate cancer 62 eribulin 62 glatiramer acetate 62 fulvestrant 62 Capecitabine 62 protease inhibitor PI 62 Genasense 62 nelfinavir 62 adjuvant therapy 62 Velcade 62 anthracycline 62 chemotherapeutic drug 62 cetuximab Erbitux R 62 valsartan 62 TACE 62 liposomal doxorubicin 61 ASA# 61 EGFR inhibitors 61 standard chemotherapy regimen 61 INTELENCE 61 Zolinza 61 biologic therapy 61 talabostat 61 fondaparinux 61 Lenalidomide 61 abiraterone 61 EGFR mutation 61 adriamycin 61 recurrent GBM 61 perifosine 61 adecatumumab 61 ramipril 61 dexamethasone Decadron 61 aromatase inhibitor 61 dacetuzumab 61 abiraterone acetate 61 Imprime PGG 61 hypomethylating agents 61 DFMO 61 refractory multiple myeloma 61 chemotherapy regimen 61 EGFR inhibitor 61 mapatumumab 61 mCRC patients 61 BMS # 61 anthracyclines 61 Avastin bevacizumab 61 mCRC 61 PREZISTA r 61 imatinib resistant 61 custirsen 61 goserelin 61 paclitaxel carboplatin 61 Alimta 61 docetaxel Taxotere ® 61 anti VEGF 61 low dose cytarabine 61 olmesartan 61 tamsulosin 61 entecavir 61 heavily pretreated 61 ZD# [001] 61 cetuximab Erbitux ® 61 fluoropyrimidine 61 disease progression 61 afatinib 61 T#I [002] 61 taxane therapy 61 tipranavir 61 Sanofi Aventis Taxotere 61 cetuximab Erbitux 61 cediranib 61 bevacizumab Avastin ® 61 platinum refractory 61 SCCHN 61 TEMODAL 61 Traficet EN 61 elotuzumab 61 sorafenib tablets 61 Taxol ® 61 melphalan prednisone 61 Avastin 61 panitumumab Vectibix 61 abatacept 61 Peg IFN 61 plus prednisone 61 Rituximab 61 bexarotene 61 entinostat 61 mitomycin 61 MabThera 61 Erbitux 61 abacavir lamivudine 60 cisplatin chemotherapy 60 dutasteride 60 Taxotere docetaxel 60 Docetaxel 60 ELOXATIN 60 xenograft models 60 G CSF 60 zalutumumab 60 Jevtana 60 teriflunomide 60 galiximab 60 Epivir 60 nitazoxanide 60 NXL# 60 rosuvastatin 60 chemotherapy gemcitabine 60 oblimersen 60 capecitabine Xeloda 60 Atrasentan 60 Rituxan 60 romiplostim 60 infusional 5-FU/LV 60 PegIntron 60 fluconazole 60 clofarabine 60 pegylated interferon alfa 2a 60 tiotropium bromide 60 maraviroc 60 HGS# 60 metaglidasen 60 ACE inhibitor 60 angiogenesis inhibitor 60 KRAS status 60 carvedilol 60 metastatic castration resistant 60 eribulin mesylate 60 daclizumab 60 EGFR TKI 60 N acetylcysteine 60 MetMAb 60 ZOLINZA 60 standard chemotherapy regimens 60 trastuzumab Herceptin 60 HGS ETR1 60 HER2 positive 60 Aplidin 60 adalimumab Humira 60 T DM1 60 TNF inhibitors 60 Revlimid lenalidomide 60 dexamethasone 60 HER2 positive breast cancer 60 letrozole Femara 60 Rituxan rituximab 60 regorafenib 60 follicular NHL 60 Everolimus 60 imatinib mesylate Gleevec 60 pamidronate 60 5 Fluorouracil 60 GRN#L 60 cyclophosphamide Cytoxan 60 AVASTIN 60 antitumor effect 60 glufosfamide 60 Pfizer Sutent 60 ganetespib 60 octreotide LAR 60 omalizumab 60 receptor tyrosine kinase inhibitor 60 immunosuppressant 60 memantine 60 interferon therapy 60 everolimus 60 active comparator 60 pegfilgrastim 60 FTY# 60 TNF inhibitor 60 tigecycline 60 REVLIMID 60 Vidaza 60 telaprevir dosed 60 trabedersen 60 valopicitabine 60 levofloxacin 60 relapsed CLL 60 intravenous bisphosphonates 60 castration resistant prostate cancer 60 Paclitaxel 60 chemotherapies 60 citalopram 60 Sunitinib 60 relapsed multiple myeloma 60 plus ribavirin 60 peginterferon alfa 2a 60 natalizumab 60 ritonavir 60 KRAS wild 60 ribavirin RBV 59 Herceptin 59 fosamprenavir 59 Folfox 59 clopidogrel Plavix 59 risedronate 59 metastatic lung cancer 59 donepezil 59 gemcitabine cisplatin 59 relapsed SCLC 59 Mylotarg 59 Atacand 59 cell lung cancer 59 allopurinol 59 nucleoside analogues 59 interferon alfa 2a 59 irbesartan 59 IMGN# 59 interferon alfa 2b 59 CoFactor 59 eplerenone 59 chemotherapy cisplatin 59 ZYVOX 59 placebo dexamethasone 59 receiving VICTRELIS 59 Omnitarg 59 evaluating tivozanib 59 irinotecan chemotherapy 59 peginterferon alfa 2b 59 Pegasys ® 59 Amplimexon 59 oral antidiabetic 59 FOLOTYN 59 candesartan 59 DOXIL 59 metastatic melanoma 59 IMC A# 59 nucleoside analogue 59 AEGR 59 pegylated interferon alfa 2b 59 Imatinib 59 VELCADE melphalan 59 pancreatic adenocarcinoma 59 Lapatinib 59 refractory CLL 59 eltrombopag 59 KRAS mutations 59 HRPC 59 resistant ovarian cancer 59 solid tumors 59 leucovorin 59 Ceplene/IL-2 59 MabCampath 59 tipifarnib 59 interferon ribavirin 59 satraplatin 59 calcitriol 59 chemotherapy docetaxel 59 non squamous NSCLC 59 depsipeptide 59 itraconazole 59 flutamide 59 IFN beta 59 aflibercept 59 fibrinolytic 59 ibandronate 59 paclitaxel Taxol ® 59 OPAXIO 59 ticagrelor 59 nilotinib Tasigna 59 recurrent ovarian cancer 59 uric acid lowering 59 imipenem 59 Zometa 59 fluvastatin 59 DAPT 59 abciximab 59 oral antiviral 59 KRAS mutant tumors 59 teriparatide 59 relapsing remitting multiple sclerosis 59 pegylated interferon alfa 59 celecoxib 59 mutated KRAS 59 follicular lymphoma 59 Faslodex 59 diagnosed multiple myeloma 59 trastuzumab Herceptin R 59 glargine 59 imatinib Gleevec ® 59 vemurafenib 59 taxane chemotherapy 59 Platinol 59 ceftriaxone 59 obatoclax 59 Rebetol 59 dose dexamethasone 59 metastatic HRPC 59 peg IFN 59 ZACTIMA 59 recurrent NSCLC 59 milatuzumab 59 adefovir 59 cytotoxic chemotherapy 59 TKIs 59 pegylated interferon alpha 59 overlapping toxicities 59 antithrombotic 59 sirolimus 59 Tyrima 59 Aflibercept 59 Yervoy 59 TELCYTA 59 metastatic hormone refractory 59 bevacizumab Avastin R 59 pemetrexed Alimta 59 TYKERB 59 viral kinetics 59 leukemia CLL 59 Fulvestrant 59 tamibarotene 59 linezolid 59 malignant pleural mesothelioma 59 sulfasalazine 59 RoACTEMRA 59 fenofibric acid 59 CA4P 59 anti androgen 59 anti angiogenic 59 sunitinib Sutent ® 59 Navelbine 59 Nexavar ® 59 dacarbazine DTIC 59 ERCC1 59 Carboplatin 59 K ras mutations 59 immunomodulator 59 Arranon 58 complete cytogenetic response 58 oral Xeloda 58 interferon IFN 58 insulin sensitizing 58 Iressa gefitinib 58 OncoVEX GM CSF 58 FOLFOX6 58 alefacept 58 refractory CTCL 58 amprenavir 58 lopinavir r 58 Xeloda ® 58 clozapine 58 Revlimid 58 anakinra 58 tumor recurrence 58 Platinol ® cisplatin 58 Abraxane 58 Tavocept 58 Neoadjuvant 58 SUTENT 58 refractory AML 58 carfilzomib 58 efavirenz Sustiva 58 Telmisartan 58 HuMax CD4 58 anticancer agent 58 androgen independent 58 MGCD# [001] 58 Betaferon ® 58 Folotyn 58 febuxostat 58 vismodegib 58 bisphosphonate 58 dabigatran etexilate 58 NNRTIs 58 leukemia AML 58 angiotensin receptor blocker ARB 58 Erbitux cetuximab 58 Combination therapy 58 ustekinumab 58 relapsed refractory 58 fluticasone 58 dasatinib Sprycel ® 58 subcutaneously administered 58 clusterin 58 Exemestane 58 preoperative chemotherapy 58 MEK inhibitors 58 plus gemcitabine 58 3TC 58 cholinesterase inhibitors 58 Cisplatin 58 pyrazinamide 58 statin 58 methotrexate MTX 58 efalizumab 58 sorafenib Nexavar R 58 romidepsin 58 VaD 58 alkylating agent 58 VAPRISOL 58 Ixempra 58 lupus nephritis 58 Nexavar sorafenib 58 strontium ranelate 58 Nexavar tablets 58 KRAS mutation 58 aflibercept VEGF Trap 58 epoetin alfa 58 bortezomib Velcade ® 58 esomeprazole 58 sustained virologic response 58 etanercept Enbrel 58 azacytidine 58 receptor inhibitor 58 ACTEMRA 58 candesartan cilexetil 58 tenofovir Viread 58 melphalan 58 simvastatin 58 amiodarone 58 insulin sensitizers 58 Protelos 58 FluCAM 58 VICTRELIS 58 Yondelis 58 tesmilifene 58 Interferon alfa 58 atazanavir 58 interferon beta 1a 58 IFN α 58 potent antiviral 58 leflunomide 58 XmAb# 58 dose cytarabine 58 3TC lamivudine Epivir 58 alpha interferon 58 prednisone prednisolone 58 MAGE A3 ASCI 58 BRAF inhibitor 58 chronic myeloid leukemia CML 58 atypical antipsychotic 58 Dapagliflozin 58 rivaroxaban 58 sevelamer 58 GnRH agonist 58 peginterferon alfa 2a Pegasys 58 proteasome inhibitor 58 odanacatib 58 superficial bladder cancer 58 darunavir ritonavir 58 Vorinostat 58 AEG# 58 voriconazole 58 liver metastases 58 Temozolomide 58 lenalidomide Revlimid R 58 unresectable 58 methotrexate therapy 58 VELCADE 58 brain metastases 58 LPV r 58 refractory NSCLC 58 peginterferon alpha 2a 58 gastrointestinal stromal tumors 58 imatinib mesylate 58 pravastatin 58 NRTI 58 relapsed refractory multiple myeloma 58 mirtazapine 58 HuMax CD# 58 cytokine refractory 58 phase IIb clinical 58 Gleevec imatinib 58 gastrointestinal stromal tumors GIST 58 Pertuzumab 58 immunomodulatory 58 relapsed MM 58 TELINTRA 58 Oxaliplatin 58 NeoRecormon 58 CIMZIA ™ 58 disease modifying 58 Cloretazine 58 palonosetron 58 Tipranavir 58 Taxol 58 OXi# 58 IFN alpha 58 tenofovir DF 58 XL# [003] 58 cangrelor 58 Roche Pegasys 58 zoledronate 58 sapacitabine 58 ofatumumab 58 telmisartan 58 amphotericin B 57 multiple myeloma 57 trastuzumab Herceptin ® 57 sulphonylureas 57 fenofibrate 57 lenalidomide dexamethasone 57 basal cell carcinoma BCC 57 losartan 57 PARP inhibitor 57 interferon gamma 1b 57 alendronate 57 LEXIVA r 57 IFN alfa 57 cisplatin gemcitabine 57 anthracycline taxane 57 ceftazidime 57 liposomal amphotericin B 57 ABC/3TC 57 MDV# 57 aliskiren 57 anti EGFR antibody 57 pegylated interferons 57 YERVOY 57 atorvastatin Lipitor 57 advanced hepatocellular carcinoma 57 budesonide 57 tolerability profile 57 bosutinib 57 severe psoriasis 57 squamous histology 57 CellCept 57 EndoTAGTM 1 57 randomized Phase III 57 Afinitor 57 CBLC# 57 selegiline 57 metastatic malignant 57 boosted protease inhibitor 57 kinase inhibitor 57 SGS# 57 neoadjuvant treatment 57 ERBITUX 57 xanthine oxidase inhibitor 57 oxaliplatin Eloxatin 57 pharmacodynamic properties 57 Telcyta 57 reboxetine 57 amlodipine 57 Roche Xeloda 57 bone metastasis 57 lenalidomide Revlimid 57 paricalcitol 57 oral chemotherapeutic agent 57 Gleevec resistant 57 Tarvacin 57 lovastatin 57 Vandetanib 57 PREZISTA rtv 57 cidofovir 57 Votrient 57 Kahalalide F 57 Adriamycin 57 EGFR mutation positive 57 tenofovir emtricitabine 57 CYC# 57 Neulasta ® 57 gastric cancer 57 Camptosar ® 57 Debio 57 Arixtra 57 Taxotere chemotherapy 57 Axitinib 57 mg kg dose 57 Epirubicin 57 MabThera rituximab 57 MGCD# [002] 57 metastatic CRC 57 ribavirin 57 doripenem 57 VFEND 57 antiviral activity 57 Glivec 57 cobicistat 57 #mg dose [001] 57 anti angiogenic therapy 57 efavirenz EFV 57 proteasome inhibitors 57 rasagiline 57 Gemzar gemcitabine 57 VEGF inhibitors 57 rapamycin 57 tolvaptan 57 NOXAFIL 57 comparator PI r 57 Ribavirin 57 metastatic colon cancer 57 Elitek 57 Navelbine ® 57 gastrointestinal stromal tumor GIST 57 LEXIVA 57 relapsing multiple sclerosis 57 hydroxychloroquine 57 APTIVUS 57 anti angiogenic agents 57 ARIMIDEX 57 infliximab Remicade 57 antiandrogen 57 Fludarabine 57 chemotherapeutic regimens 57 tipranavir ritonavir 57 APTIVUS R 57 FOLFIRI alone 57 steroid dexamethasone 57 BRAF mutation 57 Pegintron 57 hepatocellular carcinoma HCC 57 neratinib 57 adjuvant tamoxifen 57 ivabradine 57 MGd 57 Pazopanib 57 PROMACTA 57 Camptosar 57 HCV infected 57 dacarbazine chemotherapy 57 figitumumab 57 ER CHOP 57 thromboembolic events 57 REYATAZ R 57 etravirine 57 Carfilzomib 57 palifosfamide 57 trans retinoic acid 57 pro apoptotic 57 PI3K inhibitor 57 Tamibarotene 57 calcineurin inhibitors 57 sitagliptin 57 Aromasin 57 lopinavir 57 picoplatin 57 LymphoStat B 57 tamoxifen therapy 57 capecitabine Xeloda R 57 renal cell carcinoma 57 Ceflatonin 57 ranibizumab Lucentis 57 kinase inhibitors 57 Xinlay 57 metastatic pancreatic cancer 57 MIRCERA 57 antiangiogenic therapy 57 atrasentan 57 levosimendan 57 nortriptyline 57 ONTAK 57 ziprasidone 57 bosentan 57 caspofungin 57 Celecoxib 57 prostate cancer HRPC 57 Temsirolimus 57 NNRTI 57 ximelagatran 57 Fludara ® 57 adjuvant radiotherapy 57 median PFS 57 Sandostatin LAR 57 glucose lowering 57 Bezielle 57 bezafibrate 57 sipuleucel T 57 dosing regimens 57 Gemzar 57 aprepitant 57 mitoxantrone plus 57 tanespimycin 57 virologic failure 57 Interferon alpha 57 Eli Lilly Gemzar 57 surrogate endpoint 57 BARACLUDE ® 57 baminercept 57 microtubule targeting 57 PegIFN RBV 57 Telintra 57 fingolimod 57 EGFR mutant 57 amoxicillin clavulanate 57 mg dose 57 DAVANAT 57 HSP# inhibitor 57 BEACOPP 57 #mg dose [003] 57 beta interferon 57 Alemtuzumab 57 platelet inhibitor 57 MEK inhibitor 57 anti TNF alpha 57 BRAF mutations 57 Mitoxantrone 57 follicular lymphoma FL 56 splenectomized patients 56 salmeterol fluticasone 56 Alkeran 56 zanolimumab 56 complete remissions 56 low dose ritonavir 56 antiplatelet 56 endocrine therapy 56 K RAS 56 Aclasta 56 TNFα 56 cyclophosphamide methotrexate 56 peginterferon alfa 56 iodixanol 56 tumor shrinkage 56 6 mercaptopurine 56 stage IIIB 56 ISENTRESS 56 samalizumab 56 Procoralan 56 bivalirudin 56 ACZ# 56 HuLuc# 56 vinca alkaloid 56 EpCAM 56 Aptivus 56 FOLFOX chemotherapy 56 COPAXONE R 56 PD LID 56 neoadjuvant 56 Xanafide 56 Clolar 56 metastatic NSCLC 56 pCR 56 epoetin 56 antiangiogenic 56 Peginterferon 56 Mipomersen 56 adjuvant radiation 56 EGFr 56 INCB# [003] 56 comparator arm 56 5 FU leucovorin 56 Rituxan MabThera 56 SPRYCEL 56 celgosivir 56 integrase inhibitor 56 R sorafenib tablets 56 NATRECOR R 56 PKC# 56 Epratuzumab 56 NNRTI resistance 56 lipid lowering 56 Pegasys R 56 Hepsera 56 eptifibatide 56 doxorubicin HCl liposome injection 56 mitoxantrone chemotherapy 56 Vectibix monotherapy 56 Tocilizumab 56 iniparib BSI 56 CLL 56 FOLFIRINOX 56 AMN# [001] 56 fluticasone salmeterol 56 BRIM2 56 CD# monoclonal antibody 56 Xeloda capecitabine 56 estrogen receptor negative 56 EGFR antibodies 56 PSMA ADC 56 salmeterol 56 dexrazoxane 56 CCR5 antagonist 56 neoadjuvant therapy 56 Vfend 56 nucleoside analogs 56 postoperative chemotherapy 56 TYGACIL 56 Kantarjian 56 piperacillin tazobactam 56 HGS ETR2 56 docetaxel prednisone 56 lopinavir ritonavir 56 nilotinib Tasigna ® 56 Xcytrin 56 Epoetin alfa 56 ULORIC 56 LMWH 56 CR nPR 56 palifermin